dual Syk/Zap70 inhibitors University of Zurich

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedual Syk/Zap70 inhibitors University of Zurich
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase ZAP-70 inhibitorsSpleen tyrosine kinase inhibitors
TargetsTyrosine-protein kinase ZAP-70Spleen tyrosine kinase
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Zurich
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Zurich
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A